ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 1 filers reported holding ADICET BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,719,930 | -46.0% | 2,715,278 | -4.2% | 0.26% | -54.5% |
| Q2 2023 | $6,888,719 | -62.0% | 2,834,864 | -9.8% | 0.57% | -73.2% |
| Q1 2023 | $18,107,182 | -35.6% | 3,143,608 | 0.0% | 2.13% | -27.6% |
| Q4 2022 | $28,103,855 | -19.1% | 3,143,608 | +28.7% | 2.94% | -11.6% |
| Q3 2022 | $34,743,000 | -2.6% | 2,443,246 | -0.0% | 3.32% | -3.5% |
| Q2 2022 | $35,679,000 | +19.1% | 2,443,780 | +62.9% | 3.45% | +19.5% |
| Q1 2022 | $29,956,000 | – | 1,500,055 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |